| MDTC34 Stock | | | BRL 244.06 3.07 1.27% |
President
Mr. Geoffrey S. Martha is Executive Vice President and President Restorative Therapies Group., subsidiary of the Company. since June 2015 since 2015.
| Age | 53 |
| Tenure | 9 years |
| Phone | 353 1 438 1700 |
| Web | https://www.medtronic.com |
Martha previously served as Senior Vice President of Strategy and Business Development of the Company beginning in January 2015 and of Medtronic, Inc. beginning in August 2011. Prior to that, he served as Managing Director of Business Development at GE Healthcare from April 2007 to July 2011; General Manager for GE Capital Technology Finance Services from November 2003 to March 2007; Senior Vice President, Business Development for GE Capital Vendor Financial Services from February 2002 to October 2003; General Manager for GE Capital Colonial Pacific Leasing from February 2001 to January 2002; and Vice President, Business Development for Potomac Federal, the GE Capital federal financing investment bank from May 1998 to January 2001.
Medtronic Plc Management Efficiency
The company has return on total asset
(ROA) of
0.0422 % which means that it generated a profit of $0.0422 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.0833 %, meaning that it generated $0.0833 on every $100 dollars invested by stockholders. Medtronic Plc's management efficiency ratios could be used to measure how well Medtronic Plc manages its routine affairs as well as how well it operates its assets and liabilities.
Medtronic plc has accumulated 20.32
B in total debt with debt to equity ratio
(D/E) of 0.5, which is about average as compared to similar companies. Medtronic plc has a current ratio of 2.83, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Medtronic Plc until it has trouble settling it off, either with new capital or with free cash flow. So, Medtronic Plc's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medtronic plc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medtronic to invest in growth at high rates of return. When we think about Medtronic Plc's use of debt, we should always consider it together with cash and equity.
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company was founded in 1949 and is headquartered in Dublin, Ireland. MEDTRONIC DRN operates under Medical Devices classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 90000 people. Medtronic plc (MDTC34) is traded on Sao Paulo Exchange in Brazil and employs 95,000 people.
Management Performance
Medtronic plc Leadership Team
Elected by the shareholders, the Medtronic Plc's board of directors comprises two types of representatives: Medtronic Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medtronic. The board's role is to monitor Medtronic Plc's management team and ensure that shareholders' interests are well served. Medtronic Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medtronic Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sean Lennon, Chief Officer | |
| Jennifer Kirk, Global Officer | |
| Geoffrey Martha, Executive Vice President and President - Restorative Therapies Group | |
| Robert White, Executive Vice President and President of Medtronic’s Minimally Invasive Therapies Group | |
| Ryan Weispfenning, Vice President - Investor Relations | |
| Robert Hoedt, Executive Vice President and President - EMEAC | |
| Mark Ploof, Sr Services | |
| Ivan Fong, Gen VP | |
| MSc MD, Medical Scientific | |
| Karen Parkhill, CFO, Executive Vice President | |
Medtronic Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medtronic Plc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Information and Resources on Investing in Medtronic Stock
When determining whether Medtronic plc is a good investment, qualitative aspects like company
management, corporate governance, and ethical practices play a significant role. A
comparison with peer companies also provides context and helps to understand if Medtronic Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medtronic Plc Stock.
Highlighted below are key reports to facilitate an investment decision about Medtronic Plc Stock: Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
For information on how to trade Medtronic Stock refer to our
How to Trade Medtronic Stock guide.
You can also try the
Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Please note, there is a significant difference between Medtronic Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medtronic Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medtronic Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.